Biotech Values

[genisi]

But the recently published data doesn't meaningfully expand the number of patients - what happened to the invited patients, or was it only 3 invitees (the latest paper, pointed to by genisi, had 38 patients)?

The 3 extra patients in the JCO paper (n=38) are 3 patients who dropped out from the trial and were excluded from the analysis presented at the ASCO abs. (n=35).